LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 68

Search options

  1. Article ; Online: Endocan in Acute Leukemia: Current Knowledge and Future Perspectives.

    Reikvam, Håkon / Hatfield, Kimberley Joanne / Wendelbo, Øystein / Lindås, Roald / Lassalle, Philippe / Bruserud, Øystein

    Biomolecules

    2022  Volume 12, Issue 4

    Abstract: Endocan is a soluble dermatan sulfate proteoglycan expressed by endothelial cells and detected in serum/plasma. Its expression is increased in tumors/tumor vessels in several human malignancies, and high expression (high serum/plasma levels or tumor ... ...

    Abstract Endocan is a soluble dermatan sulfate proteoglycan expressed by endothelial cells and detected in serum/plasma. Its expression is increased in tumors/tumor vessels in several human malignancies, and high expression (high serum/plasma levels or tumor levels) has an adverse prognostic impact in several malignancies. The p14 endocan degradation product can also be detected in serum/plasma, but previous clinical studies as well as previously unpublished results presented in this review suggest that endocan and p14 endocan fragment levels reflect different biological characteristics, and the endocan levels seem to reflect the disease heterogeneity in acute leukemia better than the p14 fragment levels. Furthermore, decreased systemic endocan levels in previously immunocompetent sepsis patients are associated with later severe respiratory complications, but it is not known whether this is true also for immunocompromised acute leukemia patients. Finally, endocan is associated with increased early nonrelapse mortality in (acute leukemia) patients receiving allogeneic stem cell transplantation, and this adverse prognostic impact seems to be independent of the adverse impact of excessive fluid overload. Systemic endocan levels may also become important to predict cytokine release syndrome after immunotherapy/haploidentical transplantation, and in the long-term follow-up of acute leukemia survivors with regard to cardiovascular risk. Therapeutic targeting of endocan is now possible, and the possible role of endocan in acute leukemia should be further investigated to clarify whether the therapeutic strategy should also be considered.
    MeSH term(s) Acute Disease ; Endothelial Cells/metabolism ; Humans ; Leukemia, Myeloid, Acute ; Neoplasm Proteins/metabolism ; Proteoglycans/metabolism ; Sepsis
    Chemical Substances Neoplasm Proteins ; Proteoglycans
    Language English
    Publishing date 2022-03-24
    Publishing country Switzerland
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2701262-1
    ISSN 2218-273X ; 2218-273X
    ISSN (online) 2218-273X
    ISSN 2218-273X
    DOI 10.3390/biom12040492
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome.

    Pascreau, Tiffany / Tcherakian, Colas / Zuber, Benjamin / Farfour, Eric / Vasse, Marc / Lassalle, Philippe

    Critical care (London, England)

    2021  Volume 25, Issue 1, Page(s) 166

    MeSH term(s) Aged ; Biomarkers/blood ; COVID-19/blood ; COVID-19/diagnosis ; Diagnosis, Differential ; Female ; Hospitalization/trends ; Humans ; Male ; Middle Aged ; Neoplasm Proteins/blood ; Proteoglycans/blood ; Respiratory Distress Syndrome/blood ; Respiratory Distress Syndrome/diagnosis ; Retrospective Studies ; Severity of Illness Index
    Chemical Substances Biomarkers ; ESM1 protein, human ; Neoplasm Proteins ; Proteoglycans
    Language English
    Publishing date 2021-05-06
    Publishing country England
    Document type Journal Article
    ZDB-ID 2041406-7
    ISSN 1466-609X ; 1364-8535
    ISSN (online) 1466-609X
    ISSN 1364-8535
    DOI 10.1186/s13054-021-03589-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Evaluation of Endocan as a Treatment for Acute Inflammatory Respiratory Failure.

    Hureau, Maxence / Portier, Lucie / Prin, Méline / de Nadai, Patricia / Balsamelli, Joanne / Tsicopoulos, Anne / Mathieu, Daniel / Lassalle, Philippe / Grigoriu, Bogdan / Gaudet, Alexandre / De Freitas Caires, Nathalie

    Cells

    2023  Volume 12, Issue 2

    Abstract: Background: Acute respiratory distress syndrome (ARDS) is a life-threatening condition resulting from acute pulmonary inflammation. However, no specific treatment for ARDS has yet been developed. Previous findings suggest that lung injuries related to ... ...

    Abstract Background: Acute respiratory distress syndrome (ARDS) is a life-threatening condition resulting from acute pulmonary inflammation. However, no specific treatment for ARDS has yet been developed. Previous findings suggest that lung injuries related to ARDS could be regulated by endocan (Esm-1). The aim of this study was to evaluate the potential efficiency of endocan in the treatment of ARDS.
    Methods: We first compared the features of acute pulmonary inflammation and the severity of hypoxemia in a tracheal LPS-induced acute lung injury (ALI) model performed in knockout (
    Results: In our ALI model, we report higher alveolar leukocytes (
    Conclusions: Endocan appears to be an effective treatment in an ARDS-like model in C57Bl/6 mice.
    MeSH term(s) Animals ; Mice ; Lipopolysaccharides/adverse effects ; Respiratory Distress Syndrome/pathology ; Acute Lung Injury/pathology ; Pneumonia ; Respiratory Insufficiency
    Chemical Substances Lipopolysaccharides
    Language English
    Publishing date 2023-01-07
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2661518-6
    ISSN 2073-4409 ; 2073-4409
    ISSN (online) 2073-4409
    ISSN 2073-4409
    DOI 10.3390/cells12020257
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Impact of early postoperative blood glucose variability on serum endocan level in cardiac surgery patients: a sub study of the ENDOLUNG observational study.

    Chazal, Etienne / Morin, Lucas / Chocron, Sidney / Lassalle, Philippe / Pili-Floury, Sebastien / Salomon du Mont, Lucie / Ferreira, David / Samain, Emmanuel / Perrotti, Andrea / Besch, Guillaume

    Cardiovascular diabetology

    2023  Volume 22, Issue 1, Page(s) 221

    Abstract: Background: Early postoperative glycemic variability is associated with worse outcome after cardiac surgery, but the underlying mechanisms remain unknown. This study aimed to describe the relationship between postoperative glycemic variability and ... ...

    Abstract Background: Early postoperative glycemic variability is associated with worse outcome after cardiac surgery, but the underlying mechanisms remain unknown. This study aimed to describe the relationship between postoperative glycemic variability and endothelial function, as assessed by serum endocan level in cardiac surgery patients.
    Methods: We performed a post hoc analysis of patients included in the single-center observational ENDOLUNG study. Adult patients who underwent planned isolated coronary artery bypass graft surgery were eligible. Postoperative glycemic variability was assessed by calculating the coefficient of variability (CV) of blood glucose measured within 24 (CV
    Results: Data from 177 patients were analyzed. Median CV
    Conclusions: Early postoperative glycemic variability within 48 h after planned cardiac surgery does not appear to be correlated with postoperative serum endocan level.
    Clinical trial registration number: NCT02542423.
    MeSH term(s) Adult ; Humans ; Blood Glucose ; Cardiac Surgical Procedures ; Coronary Artery Bypass/adverse effects
    Chemical Substances Blood Glucose
    Language English
    Publishing date 2023-08-24
    Publishing country England
    Document type Observational Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2093769-6
    ISSN 1475-2840 ; 1475-2840
    ISSN (online) 1475-2840
    ISSN 1475-2840
    DOI 10.1186/s12933-023-01959-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Highlight on mouse endocan.

    De Freitas Caires, Nathalie / Lassalle, Philippe

    Circulation research

    2015  Volume 116, Issue 8, Page(s) e69–70

    MeSH term(s) Animals ; Cell Membrane/physiology ; Cell Membrane Permeability/physiology ; Endothelial Cells/physiology ; Male ; Proteoglycans/physiology ; Vascular Endothelial Growth Factor A/physiology
    Chemical Substances Proteoglycans ; Vascular Endothelial Growth Factor A
    Language English
    Publishing date 2015-04-10
    Publishing country United States
    Document type Comment ; Letter
    ZDB-ID 80100-8
    ISSN 1524-4571 ; 0009-7330 ; 0931-6876
    ISSN (online) 1524-4571
    ISSN 0009-7330 ; 0931-6876
    DOI 10.1161/CIRCRESAHA.115.306353
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Cleaved endocan acts as a biologic competitor of endocan in the control of ICAM-1-dependent leukocyte diapedesis.

    Gaudet, Alexandre / Portier, Lucie / Mathieu, Daniel / Hureau, Maxence / Tsicopoulos, Anne / Lassalle, Philippe / De Freitas Caires, Nathalie

    Journal of leukocyte biology

    2020  Volume 107, Issue 5, Page(s) 833–841

    Abstract: Dysregulated leukocyte diapedesis is a major contributor to acute severe inflammatory states like sepsis and acute respiratory distress syndrome, which are common conditions in critically ill subjects. Endocan is a circulating proteoglycan that binds to ... ...

    Abstract Dysregulated leukocyte diapedesis is a major contributor to acute severe inflammatory states like sepsis and acute respiratory distress syndrome, which are common conditions in critically ill subjects. Endocan is a circulating proteoglycan that binds to the leukocyte integrin LFA-1 and blocks its interaction with its endothelial ligand ICAM-1, subsequently leading to the inhibition of leukocyte recruitment. Recent data have highlighted the hypothetic role of p14, endocan's major catabolite found in the bloodstream of septic patients, as a potential antagonist of endocan, thus participating in the regulation of acute inflammation. We hereby characterize the role of p14 as a biologic competitor of endocan, through assessment of its molecular interactions with LFA-1, endocan, and ICAM-1, as well as its effects on human leukocyte trafficking. Using immunodetection assay, we report that p14 can bind to LFA-1, thus inhibiting the interaction between LFA-1 and endocan, which in turn leads to the restoration of the ICAM-1/LFA-1 interaction. In primary human T cells trafficking assays, we underline the absence of effect of p14 on ICAM-1-dependent adhesion and migration, as well as on transendothelial migration. However, in those models, p14 reverses the antimigratory effect of endocan. To conclude, our study supports the hypothesis of an antagonistic role of p14 versus endocan in its effect on the LFA-1/ICAM-1-dependent human leukocyte recruitment.
    MeSH term(s) Cell Adhesion/physiology ; Chemotaxis, Leukocyte/physiology ; Humans ; Intercellular Adhesion Molecule-1/metabolism ; Lymphocyte Function-Associated Antigen-1/metabolism ; Neoplasm Proteins/metabolism ; Proteoglycans/metabolism ; T-Lymphocytes/metabolism ; Transendothelial and Transepithelial Migration/physiology
    Chemical Substances ESM1 protein, human ; ICAM1 protein, human ; Lymphocyte Function-Associated Antigen-1 ; Neoplasm Proteins ; Proteoglycans ; Intercellular Adhesion Molecule-1 (126547-89-5)
    Language English
    Publishing date 2020-04-09
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 605722-6
    ISSN 1938-3673 ; 0741-5400
    ISSN (online) 1938-3673
    ISSN 0741-5400
    DOI 10.1002/JLB.3AB0320-612RR
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Endocan, sepsis, pneumonia, and acute respiratory distress syndrome.

    De Freitas Caires, Nathalie / Gaudet, Alexandre / Portier, Lucie / Tsicopoulos, Anne / Mathieu, Daniel / Lassalle, Philippe

    Critical care (London, England)

    2018  Volume 22, Issue 1, Page(s) 280

    Abstract: Acute respiratory distress syndrome (ARDS) and hospital-acquired pneumonia (HAP) are major problems of public health in intensive care units (ICUs), occurring in 15% of critically ill patients. Among the factors explaining ARDS development, sepsis is ... ...

    Abstract Acute respiratory distress syndrome (ARDS) and hospital-acquired pneumonia (HAP) are major problems of public health in intensive care units (ICUs), occurring in 15% of critically ill patients. Among the factors explaining ARDS development, sepsis is known as a frequent cause. Sepsis, ARDS, and HAP increase morbidity, mortality, length of stay in the ICU, and the overall costs of healthcare. The major challenge remains to identify accurately among critically ill patients those at risk of poor outcomes who could benefit from novel therapies. Endocan is released by the pulmonary endothelium in response to local or systemic injury. It inhibits mainly leukocyte diapedesis rather than leukocyte rolling or adhesion to the endothelial cells both in vitro and in vivo. Endocan was evaluated in 25 clinical reports, including 2454 critically ill patients and 452 healthy controls. The diagnostic value of endocan for sepsis or sepsis severity was equal to procalcitonin but its prognostic value was better. A predictive value for postoperative pneumonia was evidenced in two studies, and a predictive value for ARDS in four studies from three independent centers. This review presents an overview of the structure, expression, and functions of endocan. We also hereby summarize the potential applications of endocan in the prediction and prognosis of ARDS and HAP, as well as in the prognosis of sepsis.
    MeSH term(s) Critical Illness ; Female ; Healthcare-Associated Pneumonia/physiopathology ; Humans ; Intensive Care Units/organization & administration ; Male ; Middle Aged ; Neoplasm Proteins/biosynthesis ; Neoplasm Proteins/pharmacokinetics ; Proteoglycans/biosynthesis ; Proteoglycans/pharmacokinetics ; Respiratory Distress Syndrome, Adult/physiopathology ; Risk Factors ; Sepsis/physiopathology
    Chemical Substances ESM1 protein, human ; Neoplasm Proteins ; Proteoglycans
    Language English
    Publishing date 2018-10-26
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2051256-9
    ISSN 1466-609X ; 1364-8535
    ISSN (online) 1466-609X
    ISSN 1364-8535
    DOI 10.1186/s13054-018-2222-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The complex kinetics of blood endocan during the time course of sepsis and acute respiratory distress syndrome.

    Gaudet, Alexandre / Parmentier, Erika / Dubucquoi, Sylvain / Poissy, Julien / Duburcq, Thibault / Portier, Lucie / Lassalle, Philippe / De Freitas Caires, Nathalie / Mathieu, Daniel

    Critical care (London, England)

    2019  Volume 23, Issue 1, Page(s) 86

    MeSH term(s) Biomarkers/analysis ; Biomarkers/blood ; Humans ; Kinetics ; Neoplasm Proteins/analysis ; Neoplasm Proteins/blood ; Proteoglycans/analysis ; Proteoglycans/blood ; Respiratory Distress Syndrome, Adult/blood ; Respiratory Distress Syndrome, Adult/physiopathology ; Sepsis/blood ; Sepsis/physiopathology ; Time Factors
    Chemical Substances Biomarkers ; ESM1 protein, human ; Neoplasm Proteins ; Proteoglycans
    Language English
    Publishing date 2019-03-12
    Publishing country England
    Document type Letter
    ZDB-ID 2051256-9
    ISSN 1466-609X ; 1364-8535
    ISSN (online) 1466-609X
    ISSN 1364-8535
    DOI 10.1186/s13054-019-2383-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Endocan regulates acute lung inflammation through control of leukocyte diapedesis.

    Gaudet, Alexandre / Portier, Lucie / Prin, Méline / Copin, Marie-Christine / Tsicopoulos, Anne / Mathieu, Daniel / Lassalle, Philippe / De Freitas Caires, Nathalie

    Journal of applied physiology (Bethesda, Md. : 1985)

    2019  Volume 127, Issue 3, Page(s) 668–678

    Abstract: Acute respiratory distress syndrome is a severe form of respiratory failure, occurring in up to 20% of patients admitted to the intensive care unit with sepsis. Dysregulated leukocyte diapedesis is a major contributor to acute respiratory distress ... ...

    Abstract Acute respiratory distress syndrome is a severe form of respiratory failure, occurring in up to 20% of patients admitted to the intensive care unit with sepsis. Dysregulated leukocyte diapedesis is a major contributor to acute respiratory distress syndrome. Endocan is a circulating proteoglycan that binds to the leukocyte integrin leukocyte functional antigen-1 and blocks its interaction with its endothelial ligand, ICAM-1. The objective of this study was to evaluate the role of endocan in the control of acute lung inflammation. In vitro, endocan inhibited human leukocyte transendothelial migration as well as ICAM-1-dependent migration but had a very mild effect on ICAM-1-dependent adhesion. Endocan also acted as an inhibitor of transendothelial migration of mouse leukocytes. The effect of systemic administration of recombinant human endocan was assessed in a model of acute lung inflammation in BALB/c mice. Treatment with endocan 1 h after intratracheal LPS challenge reduced the alveolar inflammatory response, diminished histological features of acute lung injury, and improved respiratory function. These results highlight the anti-inflammatory role of human endocan and its protective effect against acute lung injury.
    MeSH term(s) Acute Lung Injury/drug therapy ; Animals ; Capillary Permeability/drug effects ; Cell Adhesion/drug effects ; Cell Movement/drug effects ; Drug Evaluation, Preclinical ; HEK293 Cells ; Humans ; Intercellular Adhesion Molecule-1/metabolism ; Leukocytes/drug effects ; Lipopolysaccharides ; Male ; Mice, Inbred BALB C ; Neoplasm Proteins/isolation & purification ; Neoplasm Proteins/pharmacology ; Neoplasm Proteins/therapeutic use ; Proteoglycans/isolation & purification ; Proteoglycans/pharmacology ; Proteoglycans/therapeutic use ; Respiratory Rate/drug effects ; Transendothelial and Transepithelial Migration/drug effects
    Chemical Substances ESM1 protein, human ; Lipopolysaccharides ; Neoplasm Proteins ; Proteoglycans ; Intercellular Adhesion Molecule-1 (126547-89-5)
    Language English
    Publishing date 2019-07-11
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 219139-8
    ISSN 1522-1601 ; 0021-8987 ; 0161-7567 ; 8750-7587
    ISSN (online) 1522-1601
    ISSN 0021-8987 ; 0161-7567 ; 8750-7587
    DOI 10.1152/japplphysiol.00337.2019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Endocan is a reliable biomarker during continuous renal replacement therapy.

    Hureau, Maxence / Gaudet, Alexandre / De Freitas Caires, Nathalie / Parmentier, Erika / Poissy, Julien / Duburcq, Thibault / Lassalle, Philippe / Mathieu, Daniel

    Critical care (London, England)

    2019  Volume 23, Issue 1, Page(s) 296

    MeSH term(s) Biomarkers ; Humans ; Pneumonia ; Renal Replacement Therapy ; Respiratory Distress Syndrome, Adult ; Sepsis
    Chemical Substances Biomarkers
    Language English
    Publishing date 2019-09-03
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 2051256-9
    ISSN 1466-609X ; 1364-8535
    ISSN (online) 1466-609X
    ISSN 1364-8535
    DOI 10.1186/s13054-019-2585-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top